Balaji Amines Limited · NSE:BALAMINES
Balaji Amines — Q3 FY26 Earnings Presentation
43 slides from Balaji Amines's earnings presentation, Jan 30, 2026
Slide 1: Stock exchange covering letter for Q3FY26 investor presentation
30th January, 2026 To, The General Manager-Department of The Manager-Listing Department, Corporate Services, National Stock Exchange of India Limited, BSE Limited, "Exchange Plaza", 5th Floor, Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block, Bandra-Kurla Complex, Dalal Street, Mumbai - 400 001. Band
Slide 2: Investor Presentation – January 2026
Investor Presentation – January 2026
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Balaji Amines Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securiti
Slide 4: Results Highlights, About Us, Historical Financial Performance, Annexures
Results Highlights About Us Historical Financial Performance Annexures 3
Slide 5: Q3FY26: Financial Highlights
Q3FY26 : Financial Highlights (Rs. Crore) Standalone Revenue EBITDA PAT EBITDA & PAT Margin 19 20 18 36 12 11 305 316 307 57 60 31 32 10 57 Q3FY25 Q2FY26 Q3FY26 Q3FY25 Q2FY26 Q3FY26 Q3FY25 Q2FY26 Q3FY26 Q3FY25 Q2FY26 Q3FY26 EBITDA Margin PAT Margin Consolidated Revenue EBITDA PAT EBITDA & PAT Margin
Slide 6: 9MFY26: Financial Highlights
9MFY26 : Financial Highlights (Rs. Crore) Standalone Revenue EBITDA PAT EBITDA & PAT Margin -2% -2% -11% 969 949 185 181 117 19 19 104 12 11 9MFY25 9MFY26 EBITDA Margin 9MFY25 9MFY26 9MFY25 9MFY26 9MFY25 9MFY26 PAT Margin Consolidated Revenue EBITDA PAT EBITDA & PAT Margin -2% -3% -12% 18 18 1,070 1
Slide 7: Q3 FY26 - Consolidated Performance Highlights
Q3 FY26 - Consolidated Performance Highlights Revenue from Operations for Q3FY26 stood at ₹ 331.30 crore, as compared to ₹ 340.55 crore in Q2FY26, indicating a stable operational performance. Volumes were maintained at similar levels in comparison to Q3FY25, supported by stable commodity prices and
Slide 8: New Project Highlights (1/2)
New Project Highlights (1/2) Update on New Proposed Products/Projects: • Di Methyl Ether (DME) Plant is expected to be commissioned during FY 2026-27. This has an application in the Aerosol industry apart from being used as a substitute LPG for Industrial and Commercial usage. • N-Methyl Morpholine
Slide 9: New Project Highlights (2/2)
New Project Highlights (2/2) New expansion of Rs. 750 crs in Subsidiary Balaji Speciality Chemicals Limited • Investment is being made for a wide range of products including Hydrogen Cyanide (HCN), Sodium Cyanide (NaCN) 30%(Solution), Sodium Cyanide (NaCN) 100%(Solid), Ethylene Diamine Tetra Acetic
Slide 10: Expansion Plans
Expansion Plans EXECUTED ON SCHEDULE (Methylamines) IN PROGRESS (Dimethyl Ether) • Market Leader in Methylamines production in India with installed capacity of • Dimethyl Ether (DME) with a Capacity of 1,00,000 tons per annum under Phase-3 48,000 TPA being increased to 88,000 TPA expansion a new age
Slide 11: Consolidated Statement of Profit & Loss
Consolidated Statement of Profit & Loss Balaji Amines Particulars (in Rs. Crore) Q3FY26 Q3FY25 Y-o-Y Q2FY26 Q-o-Q 9MFY26 9MFY25 Y-o-Y Total Revenue 336.29 320.59 4.90% 347.61 -3.26% 1051.26 1069.53 -1.71% Raw Material 183.76 177.60 180.05 574.96 582.65 Employee expense 18.19 18.53 19.40 58.07 56.98
Slide 12: Standalone Statement of Profit & Loss
Standalone Statement of Profit & Loss Balaji Amines Particulars (in Rs. Crore) Q3FY26 Q3FY25 Y-o-Y Q2FY26 Q-o-Q 9MFY26 9MFY25 Y-o-Y Total Revenue 306.57 304.68 0.62% 316.17 -3.04% 949.39 969.00 -2.02% Raw Material 168.17 164.11 172.52 519.67 527.31 Employee expense 16.26 17.15 17.77 52.94 52.40 Othe
Slide 13: Results Highlights, About Us, Historical Financial Performance, Annexures
Results Highlights About Us Historical Financial Performance Annexures 12
Slide 14: Amines Industry – Unique but Critical Industry with growth potential
Amines Industry – Unique but Critical Industry with growth potential Globally, ~61% of aliphatic amines and Top six companies control around 50% of In terms of the usage, Aliphatic Amines The Amines Market is projected to grow amine-based chemicals get consumed in the global capacities. China is the
Slide 15: Balaji Amines – Pioneers in Amines & Specialty Chemicals
Balaji Amines – Pioneers in Amines & Specialty Chemicals Forward integrated suite of products 50+ 40+ State-of-the-art manufacturing facilities fully equipped with Downstream products added based on strength of amine manufacturing which have value addition latest DCS technology Countries Product bas
Slide 16: Diverse Portfolio Spanning Amines, Derivatives & Specialty Chemicals
Diverse Portfolio Spanning Amines, Derivatives & Specialty Chemicals Particulars Amines Amine Derivatives Specialty & Other Chemicals o Aliphatic Amines find increasing consumption o Amine Derivatives are used to make further salts and applications in a Chemically mature Industry and other complex c
Slide 17: Robust Manufacturing Backbone with Scalable Capacities (Balaji Amines)
Robust Manufacturing Backbone with Scalable Capacities Existing Installed Capacity Proposed Capacity Total Capacity after Product Application Areas (TPA) (TPA) Expansions (TPA) Methyl Amine 88,000 - 88,000 Pharma, Agro, Dye & Rubber Ethyl Amine 22,500 - 22,500 Pharma, Agro, Dye & Rubber DMAHCL / DMA
Slide 18: Robust Manufacturing Backbone with Scalable Capacities (Balaji Speciality Chemicals)
Robust Manufacturing Backbone with Scalable Capacities Existing Installed Capacity Proposed Capacity Total Capacity after Product Application Areas (TPA) (TPA) Expansions (TPA) Pharma, Fungicides, Pesticides, Polymers and Ethylenediamine 37,350 - 37,350 Coatings Balaji Speciality Chemicals Piperazin
Slide 19: Well-Positioned Across Essential and Evolving Industries
Well-Positioned Across Essential and Evolving Industries Industry Wise - Revenue Breakup 2% 1% 3% 1% 2% 62% 28% Pharma Agrochem Paints & Resins Animal Feeds Oil & Gas Rubber Cleaning Chemicals Water Treatment Chemicals Investor Presentation 18
Slide 20: Expanding Global Footprint Across Key Export Markets
Expanding Global Footprint Across Key Export Markets • UK • Japan • US • Turkey • Argentina • Finland • Canada • Indonesia • Israel • Switzerland • India • Sri Lanka • Pakistan • Russia • Bangladesh • Malaysia • Oman • Singapore • Germany • Bahrein • Italy • Jordan • Egypt • Guatemala • South Africa
Slide 21: Trusted by Industry Leaders Across the Globe
Trusted by Industry Leaders Across the Globe Amines Amine Derivatives Specialty & Other Chemicals Investor Presentation 20
Slide 22: Integrated Value Chain Enhancing Operational Resilience
Integrated Value Chain Enhancing Operational Resilience Value-Added Products Robust Logistics Capabilities Preference for Local Sourcing Exposure to pharma sector Capex towards high-value Efficient logistics ensures safe Safety is a critical factor and Extensive usage in solvents led to derivatives
Slide 23: Distinctive Strengths Powering Our Competitive Edge
Distinctive Strengths Powering Our Competitive Edge Extensive Geographical Presence Market Leadership and Unique Positioning Strategic manufacturing footprint and global supply chain ensure Largest manufacturer of Aliphatic Amines unmatched market responsiveness, cost-efficient logistics, and in Ind
Slide 24: Focused Strategy to Enhance Value Across the Value Chain
Focused Strategy to Enhance Value Across the Value Chain Target fast growing industries Value Added Products Cater to fast growing industries, namely, Focus towards high-value derivatives and pharmaceuticals, agro-chemicals, refineries, specialty chemicals with an aim to move up water treatment, rub
Slide 25: Poised for the Next Phase of Scalable, Profitable Growth (1/2)
Poised for the Next Phase of Scalable, Profitable Growth (1/2) Strategically Located Project Accorded Mega Balaji Specialty Product Profile Plant Project Status Chemicals All the plants of Balaji Amines are In Phase-1 of Greenfield Project Electronic Grade DMC Existing located in and around Solapur,
Slide 26: Poised for the Next Phase of Scalable, Profitable Growth (2/2)
Poised for the Next Phase of Scalable, Profitable Growth (2/2) New Products = First High Demand for Solar Power Plant Mover advantage Products Significant opportunity exists to The demand of Methylamines has Out of the planned 20 MW introduce new products & gain First increased in India. High demand
Slide 27: About Balaji Speciality Chemicals
About Balaji Speciality Chemicals 01 02 03 Balaji Speciality Chemicals Limited (BSCL) is Commenced its commercial operations in June 2019 from Manufacturing products such as Ethylene Diamine (EDA), BAL owns 55% in subsidiary Balaji Speciality Chemicals its state of-the-art manufacturing facility in
Slide 28: About Balaji Sarovar Premiere Hotel
About Balaji Sarovar Premiere Hotel o Commenced Operations in October 2013 Hotel Balaji Sarovar Premier is the only 5 star hotel in Solapur o Invested Rs. 110 crore in the Hotel Project via mix of Debt and Equity o Tied up with Sarovar Group for the Management of the Hotel on Management Fee + Revenu
Slide 29: Balaji Sarovar Premiere – Q3FY26 Operating Matrix
Balaji Sarovar Premiere – Q3FY26 Operating Matrix Constitutes Rs 981.04 129 Rooms 2.92% of Lakhs Rs. 5,445 from Hotel Division ARR Total Revenue Business 82% Rs. 4,452 Occupancy Rate RevPAR Renowned Five Star Hotel In the City of Solapur ADR: Average Daily Rate RevPAR: Revenue per Available Room Inv
Slide 30: Results Highlights, About Us, Historical Financial Performance, Annexures
Results Highlights About Us Historical Financial Performance Annexures 29
Slide 31: Consolidated Performance Highlights
Consolidated Performance Highlights Revenue (Rs. Crs.) EBITDA (Rs. Crs.) PAT (Rs. Crs.) 2,338 2,371 637 624 418 406 1,671 1,318 1,430 379 353 244 232 265 159 2021 2022 2023 2024 2025 2021 2022 2023 2024 2025 2021 2022 2023 2024 2025 EBITDA Margin (%) PAT Margin (%) RoE (%) 28.8% 27.3% 18.5% 17.9% 31
Slide 32: Strong Core ROCE Profile
Strong Core ROCE Profile Particulars (Rs. Crs.) FY25 FY24 Consolidated Debt 11 20 During the year the following plants have been commissioned 1) Methylamines Plant Consolidated Networth 2018 1893 2) N-Butylamine Plant – Unit IV 3) Rooftop Solar Power Plants at various units Total Capital Employed 20
Slide 33: Consistent Dividend Payout
Consistent Dividend Payout 550% 550% 500% 300% 200% 160% FY20 FY21 FY22 FY23 FY24 FY25 Particulars (Rs. per share) FY20 FY21 FY22 FY23 FY24 FY25 Consolidated Book Value 206 281 406 524 584 623 Consolidated EPS 32 74 114 100 63 49 Dividend 3.20 4.00 6.00 10.00 11.00 11.00 Investor Presentation 32
Slide 34: Results Highlights, About Us, Historical Financial Performance, Annexures
Results Highlights About Us Historical Financial Performance Annexures 33
Slide 35: Balaji Amines Ltd - Progressing steadily
Balaji Amines Ltd - Progressing steadily Unit 4: Increased Unit 4 : Capex for Phase 2 & 3 of Greenfield Capex to be capacity utilization & 1 Capex Phase - 2 & 3 completed till FY 2027 2 capacity additions of Higher capacity utilization of new Ethylamines plant Phase - 1 capex Dimethyl Ether (DME) pl
Slide 36: Highly Experienced Management Team
Highly Experienced Management Team Mr. A. Prathap Reddy Mr. N. Rajeshwar Reddy Executive Chairman Whole Time Director • Civil Engineer by Education. Incorporated BAL in 1988 • Commerce Graduate having over 48 years of • BAL's continuing success is a testimony to his experience across industries entr
Slide 37: Awards & Certificates – A Testimony of our capabilities
Awards & Certificates – A Testimony of our capabilities ISO Certificate Three Star Export House ISO Certificate BEST CEO (CHEMICAL INDUSTRY) AWARD TO SHRI ANDE PRATHAP REDDY BY BUSINESS TODAY GROUP ISO 9001 : 2015 Certificate Certificate of Merit - CHEMEXCIL First Award - CHEMEXCIL WHO GMP Certifica
Slide 38: Awards & Certificates – A Testimony of our capabilities
Awards & Certificates – A Testimony of our capabilities Mahatma Award for Sustainable “Company of the Year” in International Tourism & Product Innovator of the Year in Distinguished Contribution in the Excellent CSR in Water and Responsible Business Chemicals at FICCI Chemicals Hospitality Award For
Slide 39: Awards & Recognition - A Testimony of our capabilities
Awards & Recognition - A Testimony of our capabilities On October 8, 2025, Balaji Amines Limited bagged the Western Zone Award in the Large Scale Enterprise category for its outstanding work in the Healthcare sector. The award was received by Mr. Arun Masal, General Manager – Finance, and Mr. Vinod
Slide 40: Awards & Recognition - A Testimony of our capabilities
Awards & Recognition - A Testimony of our capabilities On January 28, 2025, Balaji Amines Limited was honored with the “Rasayan Udyog Shri” award by the Indian Chemical Society at its centennial celebration in Mumbai. Chairman Shri A. Pratap Reddy received the award from Prof. G. D. Yadav in the pre
Slide 41: ESG & CSR Initiatives
ESG & CSR Initiatives Donated Bus for Punyashlok Ahilyadevi Holkar Solapur University, Contructed classroom at RR Patil School & Jr College @ Constructed classroom at Baburao Patil Vidhyalay Gotewadi, Mohol, Solapur dt. 10.12.2024 Penur,Mohol, Solapur dt 07.06.2024 Solapur dt.09.10.2024 Constructed
Slide 42: ESG & CSR Initiatives
ESG & CSR Initiatives Constructed Classroom at ZPHS Chengal School, Mandal Bhimgal, Construction of Toilet Block at Indira Kale Prashala, Jalkotwadi, dt. Distributed Sanitary Napkin Incinerator and Vending Machine at Nizamabad, dt. 04.01.2025 25.03.2025 Vishwabhushan Vidyalay, Solapur dt.30.09.2024
Slide 43: THANK YOU
Company : Balaji Amines Ltd. CIN - L24132MH1988PLC049387 Email - cs@balajiamines.com www.balajiamines.com Investor Relations Advisors : MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services Mr. Nikunj Seth Nikunj.seth@in.mpms.mufg.com Ms. Se